1. Home
  2. IPO
  • Anondita Medicare Ltd IPO
Anondita Medicare Ltd logo

Anondita Medicare IPO

  • Status: Closed
  • RHP:
  • ₹ 274,000 / 2000 shares

    Minimum Investment

IPO Listing Details

  • Listing Date

    01 Sep 2025

  • Listing Price

    ₹ 275.50

  • Listing Change

    90.00%

  • Last Traded Price

    ₹ 713.10

Anondita Medicare IPO Details

  • Open Date

    22 Aug 2025

  • Close Date

    26 Aug 2025

  • Listing Date

    01 Sep 2025

  • IPO Price Range

    ₹ 137 to ₹145

  • IPO Size

    ₹ 69.50 Cr

  • Listing Exchange

    NSE SME

Open Free Demat Account

+91
Resend OTP

By proceeding, you agree to all T&C*

hero_form
Timeline Subscription Status Financials SWOT FAQ Contacts

Anondita Medicare IPO Timeline

Anondita Medicare IPO Subscription Status

Last Updated: 26 August 2025 6:34 PM by 5paisa

Anondita Medicare Limited, launching a ₹69.50 Cr IPO, is a leading manufacturer of flavored male condoms under its flagship brand “COBRA,” producing around 562 million units annually. The company exports to regions including Southeast Asia, Africa, and the Middle East, while working closely with global health bodies, NGOs, and governments to promote family planning and public health. With a strong distribution network, it partners with wholesalers, retailers, e-commerce platforms, and government programs to ensure wide accessibility and timely supply of its products.
 
Established in: 2024
Managing Director: Mr. Anupam Ghosh

Peers

● Cupid Limited

Anondita Medicare Objectives

● The company will utilize ₹6 crore for capital expenditure on machinery.
● Will allocate ₹35 crore towards meeting its working capital requirements.
● A portion of the funds will be used for unidentified acquisitions and strategic growth.

Anondita Medicare IPO Size

Types Size
Total IPO Size ₹46.97 Cr
Offer For Sale ₹9.28 Cr
Fresh Issue ₹37.70 Cr

 

Anondita Medicare IPO Lot Size

Application Lots Shares Amount
Retail (Min) 2 2,000 2,74,000
Retail (Max) 2 2,000 2,74,000
S-HNI (Min) 3 3,000 4,11,000
S-HNI (Max) 6 6,000 8,22,000
B-HNI (Min) 7 7,000 9,59,000

Anondita Medicare IPO Reservation

Investors Category Subscription (times) Shares Offered Shares bid for Total Amount (Cr.)*
QIB 153.03 9,06,000 13,86,48,000 2,010.40
NII (HNI) 531.82 6,81,000 36,21,72,000 5,251.49
Retail 286.20 15,86,000 45,39,08,000 6,581.67
Total** 300.89 31,73,000 95,47,28,000 13,843.56

 

*The "Shares Offered" and "Total Amount" are calculated using the upper limit of the issue price range.
**Shares allocated to anchor investors (or market makers) are excluded from the total number of shares offered.

Profit and Loss

Balance Sheet

Particulars (in Rs. Crores) FY23 FY24 FY25
Revenue 36.14 46.56 77.13
EBITDA 3.58 9.09 25.65
PAT 0.35 3.84 16.42
Particulars (in Rs. Crores) FY23 FY24 FY25
Total Assets 37.80 42.92 78.27
Share Capital 13.29 0 0
Total Borrowings 22.66 24.01 27.39
Particulars (in Rs. Crores) FY23 FY24 FY25
Net Cash Generated From / (used in) operating activities -9.42 10.55 -9.80
Net Cash Generated From / (used in) investing activities -0.25 -6.54 -22.91
Net Cash Generated From / (used in) financing activities 9.91 -3.99 33.23
Net Increase (Decrease) In Cash And Cash Equivalents 0.16 0.01 -0.14


Strengths

1. Large-scale production capacity of 562 million condoms annually.
2. Flagship brand “COBRA” has strong market recognition.
3. Robust distribution network ensuring timely product availability.
4. Strong partnerships with governments, NGOs, and health organizations.

Weaknesses

1. Heavy reliance on government health programs and contracts.
2. Limited product diversification beyond flavored male condoms.
3. Brand awareness relatively weaker in developed global markets.
4. Vulnerable to regulatory changes in health sector policies.

Opportunities

1. Rising global demand for affordable contraceptive solutions.
2. Expansion potential in untapped Latin American markets.
3. Increasing online sales through e-commerce distribution platforms.
4. Growing acceptance of flavored condoms in urban populations.

Threats

1. Intense competition from global condom manufacturing giants.
2. Fluctuations in raw material costs affecting profitability.
3. Cultural and social barriers limiting product acceptance..
4. Strict international regulations impacting export market access
 

1. Established brand presence with flagship “COBRA” condom range.
2. Strong distribution network across domestic and international markets.
3. Consistent demand supported by health programs and NGOs.
4. Growth potential through e-commerce and emerging global markets.

Anondita Medicare operates in the global contraceptive and healthcare products industry, with strong demand driven by rising awareness of family planning and sexual health. With its flagship brand “COBRA,” the company exports widely across Southeast Asia, Africa, and the Middle East. Leveraging collaborations with governments, NGOs, and global health bodies, it ensures consistent demand. Growing e-commerce penetration and expanding urban markets further enhance long-term growth prospects for the company.

Upcoming IPOs

View all IPOs
  • Companies
  • Type
  • Opening On

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
Resend OTP

By proceeding, you agree to all T&C*

footer_form

FAQs

Anondita Medicare IPO opens from August 22, 2025 to August 26, 2025.

The size of Anondita Medicare IPO is ₹69.50 Cr.

The price band of Anondita Medicare IPO is fixed at ₹137 to ₹145 per share.

To apply for Anondita Medicare IPO, follow the steps given below:
 
●    Login to your 5paisa account and select the issue in the current IPO section    
●    Enter the number of lots and the price at which you wish to apply for the Anondita Medicare  IPO.    
●    Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.    
 
You will receive a mandate notification to block funds in your UPI app.

The minimum lot size of Anondita Medicare IPO is of 2 lots consisting of 2,000 shares and the investment required is ₹2,74,000.

The share allotment date of Anondita Medicare IPO is August 28, 2025

The Anondita Medicare IPO will likely be listed on September 1, 2025.

Narnolia Financial Services Ltd is the book running lead manager for Anondita Medicare IPO.

Anondita Medicare plans to utilise the raised capital from the IPO for:
● The company will utilize ₹6 crore for capital expenditure on machinery.
● Will allocate ₹35 crore towards meeting its working capital requirements.
● A portion of the funds will be used for unidentified acquisitions and strategic growth.